VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,852,000 | +22.4% | 122,711 | -16.1% | 0.00% | 0.0% |
| Q1 2018 | $2,330,000 | -29.9% | 146,299 | -36.9% | 0.00% | -50.0% |
| Q3 2017 | $3,322,000 | -28.2% | 231,842 | -13.3% | 0.00% | 0.0% |
| Q2 2017 | $4,629,000 | +21.8% | 267,546 | -22.4% | 0.00% | 0.0% |
| Q1 2017 | $3,802,000 | +12.0% | 344,689 | +47.4% | 0.00% | 0.0% |
| Q4 2016 | $3,396,000 | -68.0% | 233,866 | -46.0% | 0.00% | -66.7% |
| Q3 2016 | $10,625,000 | +30.9% | 432,801 | +7.4% | 0.01% | +50.0% |
| Q2 2016 | $8,114,000 | -18.3% | 402,925 | +6.6% | 0.00% | -20.0% |
| Q1 2016 | $9,932,000 | -66.4% | 377,843 | +29.9% | 0.01% | -66.7% |
| Q4 2015 | $29,566,000 | -88.5% | 290,884 | -79.8% | 0.02% | -88.2% |
| Q3 2015 | $257,085,000 | -27.3% | 1,441,130 | -9.4% | 0.13% | -20.6% |
| Q2 2015 | $353,449,000 | +23.1% | 1,591,084 | +10.1% | 0.16% | +23.1% |
| Q1 2015 | $287,116,000 | +65.9% | 1,445,747 | +19.6% | 0.13% | +66.7% |
| Q4 2014 | $173,067,000 | +28.6% | 1,209,275 | +17.9% | 0.08% | +27.9% |
| Q3 2014 | $134,603,000 | +18.4% | 1,026,019 | +13.8% | 0.06% | +22.0% |
| Q2 2014 | $113,698,000 | +18.1% | 901,378 | +23.4% | 0.05% | +11.1% |
| Q1 2014 | $96,281,000 | +244.2% | 730,671 | +206.5% | 0.04% | +221.4% |
| Q4 2013 | $27,974,000 | +29.9% | 238,371 | +15.4% | 0.01% | +27.3% |
| Q3 2013 | $21,542,000 | +26.7% | 206,560 | +4.6% | 0.01% | +10.0% |
| Q2 2013 | $17,009,000 | – | 197,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |